Figures & data
Figure 1 Flowchart of survey participants (general practitioners and urologists).
Abbreviation: GPs, general practitioners.
Table 1 Specialty of respondents
Table 2 Characteristics of respondents by general practitioners and urologists, n (%)
Table 3 Questions on PSA testing I by general practitioners and urologists, n (%)
Table 4 Questions on PSA testing II by general practitioners and urologists, n (%)
Table 5 Questions on PSA testing III, n (%)
Table 6 Questions on PSA testing IV, n (%)
Figure 2 Number of PSA test performed during the last 2 weeks by general practitioners (n=41) and urologists (n=14).
Abbreviations: GPs, general practitioners; PSA, prostate-specific antigen.
Figure 3 PSA level at which general practitioners (n=41) and urologists (n=14) would take further actions for an asymptomatic patient who received a PSA test within an early detection examination.
Abbreviations: GPs, general practitioners; PSA, prostate-specific antigen.
Table 7 Case scenarios, n (%)
Figure 4 Case scenario 1a: Minimum age at which general practitioners (n=41) and urologists (n=14) would recommend a PSA test to an asymptomatic patient of a certain age without risk factors, if they would recommend one.
Abbreviation: GPs, general practitioners.
Table 8 Questions on guidelines and recommendations I by general practitioners and urologists I, n (%)
Table 9 Questions on guidelines and recommendations II by general practitioners and urologists
Table 10 Questions on guidelines and recommendations III by general practitioners and urologists, n (%)
Table 11 Questions on daily practice by general practitioners and urologists, n (%)
Table 12 Questions on PSA testing and prostate cancer risk, n (%)
Figure 5 Change in handling PSA testing during the last 10 years for GPs (n=41) and urologists (n=14).
Abbreviations: GPs, general practitioners; PSA, prostate-specific antigen.
Figure 6 Score in agreement for undergoing a PSA test in the future for male general practitioners (GPs) (n=36) and male urologists (n=14).
Abbreviations:GPs, general practitioners; PSA, prostate-specific antigen.
Figure 7 Scores of GPs (n=41) and urologists (n=14) on the question if they think that the reduction of PCa-related mortality by early detection based on PSA testing is proven.
Abbreviations: GPs, general practitioners; PSA, prostate-specific antigen..
Table S1 Questions on PSA testing V by general practitioners and urologists, n (%)
Table S2 Questions on digital rectal examining by general practitioners and urologists, n (%)